SEC Form 4 · accession 0001203311-16-000183
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Darren S Cline
Officer — EVP, Commercial
Period of report
Dec 13, 2016
Accepted (ET)
Dec 15, 2016 · 7:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 13, 2016 | M | 10,000 | $26.10 | A | 65,743 | D | |
| Common StockF2,F1 | Dec 13, 2016 | S | 8,806 | $63.2525 | D | 56,937 | D | |
| Common StockF1 | Dec 13, 2016 | M | 2,761 | $18.46 | A | 59,698 | D | |
| Common StockF3,F1 | Dec 13, 2016 | S | 1,194 | $64.349 | D | 58,504 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F4 | $18.46 | Dec 13, 2016 | M | 2,761 | D | — | Feb 28, 2022 | Common Stock | 2,761 | 0 | D |
| Non-Qualified Stock Option (right to buy)F5 | $26.10 | Dec 13, 2016 | M | 10,000 | D | — | Aug 20, 2022 | Common Stock | 10,000 | 926 | D |
Explanation of responses
- F1Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F2Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $62.73 to $63.59. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F3Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $63.75 to $64.55. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F4Shares vested at a rate of 25% on 2/28/13 and monthly thereafter until all shares were fully vested on 2/28/16.
- F5Shares vested at a rate of 25% on 8/20/13 and monthly thereafter until all shares were fully vested on 8/20/16.